Clinical trials represent the crucial interface between innovative cancer research and successful therapy. They give patients direct access to the latest therapeutic developments and provide the possibility of promptly benefiting from current research findings. You can find information for patients about clinical trials in the "For Patients" section. Around 500 oncological clinical studies and Investigator Initiated Trials (IITs) are currently conducted at the National Center for Tumor Diseases (NCT) in Heidelberg.